Current Pain and Headache Reports

, Volume 7, Issue 6, pp 466–474

Current and potential future drug therapies for tension-type headache

Authors

  • Sait Ashina
    • Danish Headache CenterUniversity of Copenhagen and Department of Neurology, Glostrup University Hospital
  • Messoud Ashina
    • Danish Headache CenterUniversity of Copenhagen and Department of Neurology, Glostrup University Hospital
Article

DOI: 10.1007/s11916-003-0063-8

Cite this article as:
Ashina, S. & Ashina, M. Current Science Inc (2003) 7: 466. doi:10.1007/s11916-003-0063-8

Abstract

Tension-type headache is a common primary headache with tremendous socioeconomic impact. Establishment of an accurate diagnosis is important before initiation of any pharmacologic therapy. Simple analgesics and nonsteroidal anti-inflammatory drugs are the mainstays of treatment of episodic tension-type headache. The tricyclic antidepressant amitriptyline is the drug of choice in the preventive treatment of chronic tension-type headache. Progress in basic neuroscience has emphasized the importance of nitric oxide inhibition and N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid receptor antagonism in the treatment of chronic pain. It has been demonstrated that inhibition of nitric oxide is effective in chronic tension-type headache. These interesting data indicate that more specific and effective treatment possibilities will emerge in the future.

Copyright information

© Current Science Inc 2003